Interventional Cardiology & Peripheral Vascular Devices Market - By Product (Interventional Catheters, Guidewires, Stents, PTCA Balloons, Atherectomy Devices, Embolic Protection Devices), Application, End-use & Global Forecast to 2032

Interventional Cardiology & Peripheral Vascular Devices Market - By Product (Interventional Catheters, Guidewires, Stents, PTCA Balloons, Atherectomy Devices, Embolic Protection Devices), Application, End-use & Global Forecast to 2032

Interventional Cardiology & Peripheral Vascular Devices Market Size

Interventional Cardiology & Peripheral Vascular Devices Market size exceeded USD 22 billion in 2022. The industry is expected to register more than 7.5% CAGR through 2023-2032, considering low physical activity engagement and rising chronic disease incidence.
 

Lifestyle changes and the adoption of unhealthy habits including alcohol consumption are contributing to the growing prevalence of cardiovascular diseases such as heart attacks. Coronary catheterization and peripheral vascular interventional procedures will emerge as a preferred intervention to lower the disease burden. Obesity is also recognized as one of the public health problems worldwide.
 

Obesity is considered a risk factor for peripheral arterial disease development. The increase in the obese population will therefore accelerate hospital admissions and create lucrative growth opportunities for manufacturers of cardiology equipment and peripheral vascular medical devices. However, these devices require high capital investment, and their regulatory approvals are time-consuming. They possess high-risk levels and are subject to strict regulations, thereby restricting market expansion.
 

Interventional Cardiology & Peripheral Vascular Devices Market Analysis

In terms of application, the interventional cardiology & peripheral vascular devices market from the congenital heart defect correction segment was valued at over USD 3 billion in 2022. This is attributed to the high burden of atrial septal defects among pediatric patients. Based on statistics from the CDC, nearly 2,118 babies are diagnosed with an atrial septal defect in the U.S. each year. In addition, the prevalence of diabetes mellitus has also increased in developed countries. Since diabetes is a leading cause of congenital heart defects, the use of interventional cardiology devices will surge globally.
 

The interventional cardiology & peripheral vascular devices market share from the ambulatory surgical centers end-use segment is poised to depict over 8% CAGR through 2023-2032, driven by the shifting preference toward minimally invasive procedures. These surgical practices are associated with reduced risks, convenience, and other attributes. The availability of skilled healthcare personnel is also contributing to the growing preference for treatment in ASCs. These factors, alongside the increasing number of patients with heart diseases, will augment the usage of interventional cardiology and peripheral vascular equipment in these centers.
 

North American interventional cardiology & peripheral vascular devices market size is anticipated to surpass USD 13 billion by 2032. The presence of state-of-the-art healthcare facilities for conducting minimally invasive cardiac procedures is among the major growth drivers. In the U.S., the number of elderly people susceptible to chronic diseases has also risen. Furthermore, the rising disposable income and healthcare expenditure are expected to amplify product consumption across the region.
 

Interventional Cardiology & Peripheral Vascular Devices Market Share

The strategic landscape of the interventional cardiology & peripheral vascular devices market consists of companies such as

• B. Braun Melsungen AG
• C.R. Bard (BD)
• Cardinal Health
• Medtronic plc
• Teleflex Inc., W. L.
• Gore & Associates Inc.
• Cook Medical,
• Boston Scientific Corporation
• Biotronik SE & Co. K
• AngioDynamics
• and Abbott Laboratories

These firms are focusing on advanced product developments and other strategies to gain a competitive edge and reinforce their foothold in the industry.
 

Impact of global inflation on interventional cardiology & peripheral vascular devices industry trends

Like manufacturing industries, the ongoing inflation has impacted several other industry verticals including medical devices. According to the U.S. Bureau of Labor Statistics, in 2022, the producer price indexes for medical supplies and equipment were significantly higher as compared to a year earlier. The Russia-Ukraine war has also resulted in a price surge in medical equipment. Factors such as these may limit the development of interventional cardiology and peripheral vascular systems over the foreseeable future.
 

The interventional cardiology & peripheral vascular devices market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million and volume in Units from 2018 to 2032 for the following segments

Click here to Buy Section of this Report

By Product

• Interventional catheters
• Guidewires
• Stents
  • Bioabsorbable stents
  • Drug eluting stents
  • Bare metal stents
  • Others
• PTCA balloons
• Atherectomy devices
• Chronic total occlusion devices
• Synthetic surgical grafts
• Embolic protection devices
• IVC filters
• Others

Application

• Congenital heart defect correction
• Coronary thrombectomy
• Angioplasty
• Valvuloplasty
• Percutaneous valve repair
• Others

End-use

• Hospitals
• Ambulatory surgical centers
• Others

The above information is provided for the following regions and countries

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Poland
  • The Netherlands
  • Sweden
  • Austria
  • Denmark
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Thailand
  • Singapore
  • Indonesia
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Chile
  • Colombia
  • Peru
• Middle East & Africa
  • Saudi Arabia
  • South Africa
  • UAE
  • Israel
  • Egypt